Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
November 9, 2021 6:00 AM ESTBOSTON, Nov. 9, 2021 /PRNewswire/ --Â Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal 2022, which ended October 2, 2021, are available on its Investor Relations website.
... More
